Gilder Gagnon Howe & CO LLC Profound Medical Corp. Transaction History

Gilder Gagnon Howe & CO LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.99 - $9.3 $3,598 - $8,388	-902 Reduced 0.62%	145,613 $588,000
Q2 2022 Aug 15, 2022	SELL	$6.34 - $9.53 $106,080 - $159,455	-16,732 Reduced 10.25%	146,515 $1.07 Million
Q1 2022 May 16, 2022	BUY	$8.16 - $11.33 $14,084 - $19,555	1,726 Added 1.07%	163,247 $1.47 Million
Q4 2021 Feb 14, 2022	SELL	$10.38 - $15.2 $903 - $1,322	-87 Reduced 0.05%	161,521 $1.81 Million
Q3 2021 Nov 15, 2021	SELL	$13.6 - $17.88 $476,462 - $626,407	-35,034 Reduced 17.82%	161,608 $2.37 Million
Q2 2021 Aug 16, 2021	BUY	$16.0 - $20.59 $365,728 - $470,646	22,858 Added 13.15%	196,642 $3.22 Million
Q1 2021 May 17, 2021	BUY	$19.16 - $28.09 $773,450 - $1.13 Million	40,368 Added 30.26%	173,784 $3.5 Million
Q4 2020 Feb 16, 2021	SELL	$16.4 - $22.9 $8,446 - $11,793	-515 Reduced 0.38%	133,416 $2.74 Million
Q3 2020 Nov 16, 2020	BUY	$14.05 - $18.13 $1.88 Million - $2.43 Million	133,931 New	133,931 $2.36 Million

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.